Masimo (MASI) Free Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -3.34% |
| Sep 27, 2025 | 10.17% |
| Jun 28, 2025 | 3.17% |
| Mar 29, 2025 | 45.84% |
| Dec 28, 2024 | -1.14% |
| Sep 28, 2024 | -10.32% |
| Jun 29, 2024 | 25.82% |
| Mar 30, 2024 | 2.26% |
| Dec 30, 2023 | 5.77% |
| Sep 30, 2023 | -19.46% |
| Jul 1, 2023 | -25.29% |
| Apr 1, 2023 | -16.20% |
| Dec 31, 2022 | -20.55% |
| Oct 1, 2022 | 21.60% |
| Jul 2, 2022 | 26.58% |
| Apr 2, 2022 | -22.25% |
| Jan 1, 2022 | -14.04% |
| Apr 3, 2021 | 30.20% |
| Mar 28, 2020 | 22.91% |
| Sep 28, 2019 | 12.51% |
| Jun 29, 2019 | 19.17% |
| Mar 30, 2019 | 10.88% |
| Dec 29, 2018 | 67.91% |
| Sep 29, 2018 | 28.83% |
| Jun 30, 2018 | 57.39% |
| Mar 31, 2018 | 24.00% |
| Dec 30, 2017 | 22.60% |
| Sep 30, 2017 | -18.05% |
| Jul 1, 2017 | -54.01% |
| Apr 1, 2017 | -14.93% |
| Dec 31, 2016 | 69.34% |
| Oct 1, 2016 | 9.66% |
| Jul 2, 2016 | 13.45% |
| Apr 2, 2016 | -2.63% |
| Jan 2, 2016 | 22.08% |
| Apr 4, 2015 | -43.85% |
| Sep 27, 2014 | 5.64% |